IQBAL, A.; ABBASI, Z. A. .; NAEEM, F. . Benefits of six week and personalized dosing of pembrolizumab considering ongoing delta variant surge. Journal of the Pakistan Medical Association, [S. l.], v. 72, n. 3, 2022. DOI: 10.47391/JPMA.4660. Disponível em: https://www.jpma.org.pk/index.php/public_html/article/view/4660. Acesso em: 25 may. 2026.